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importance of the fact that our 2 groups observe, after low-dose 
UVB, similar LC lesions. 
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Effectiveness of Azelaic Acid As a Depign1enting and Chemotherapeutic 
Agent 
To th e Editor: 
At first sight it mi ght appear that the findings rcpo rted by Pathak 
et al in the September iss ue o f the J ourn al (pp 222-228) prove 
that azelaic acid has no va luc as a chcmotherapcuti c agcnt, and 
that they co ntradi ct obse rvations of ours, and others, published 
over th e past 7 yea rs, and extended by our report published in 
the sam e iss ue (pp 216- 221). In fact, the results of the Boston 
gro up 's stud y entirely confirm what we have been emphasizing 
all along, i.e . , that azela ic acid has little o r no effect on the maj o rity 
of no rm al melanocytes in vivo (a 20% topical cream) o r in vitro 
at concentrati ons of 10- 3 M, or less . We have also reported 0 
Inves t Dermatol 82:542, 1984) tha t at 10 - 3 M it has no effect on 
melanoma cells in culture, and it is evident from the gra phs in 
Fig 1 of our current paper th at at this concentration it ha s, in fact, 
a stimulating effect on g rowth of Harding-Passey and Cloud man 
cells in culture. It is only at higher concentrations (> 10- 3 M) that 
we find an effect on cell proliferation and/or viability, and the 
Boston group and Leibl et al (Arch Dermatol Res 276:273a, 1984) 
also found this. All 3 groups supplement their cu ltu re media with 
fetal calf serum, and in this connection it may be pointed out that 
Schachtschabel (Proceedings of the Vth European Workshop on 
Melanin Pigm entation , 1984, p 43) repo rted a significant inhi-
bition of growth of Hardin g-Passey melanoma cells with azelaic 
acid at 1 X 10 - 3 M . It might be of interest for the o ther 3 g roups 
mentioned to repea t their experiments using serum-free medium. 
Pathak et al suggest, but do no t substantiate w ith data, tha t 
the effect on g rowth and viability observed by them with azela ic 
acid at 10 - 2 M results from "perturbations o( hydrogen ion co n-
centration." In our present paper we conclusively show that the 
effects arc no t du e to " perturbed" pH, o r high osmolarity, and 
that ano th er dicarboxylic acid, adipic acid (C 6 ) at similar concen-
trations, pH, and osmolarity, in similar medium , does not produce 
the same effects as azelaic acid; Leibl et al reported the same lack 
of effect w ith ad ipic acid, confirmin g the selective effect of azelaic 
acid . They also confirmed its beneficial clini ca l effect on lentigo 
maligna. 
Pathak et al state that they have found all putative melanocy-
totoxic agents to be .invariably toxic for both normal and abnor-
mal melanocytes, and ex press surprise that azela ic acid shou ld be 
se!c.:ctive in this res pect. It is-and thi s is one of its main advan-
tages over other agents , leadin g to the cos metica ll y accep tab lc 
rcsult in , for cxample Icntigo maligna and cho las ma-th at therc 
is no residual hypochro mia at the site orthe resolved lesion. Many 
of the agents referred to by thcm such as 4- 0 HA are substrates 
of tyrosinase and arc used up, lead ing to production of roxic 
intermed iates which damage melanocy tes . Azelaic acid is a com-
petitive inhibitor of tyrosinase, and is not used up. Ir acts, in fact, 
as we have reported (Passi et aI, Biochem Pharmacol 
33:103-108,1984) against the mitochondrial ox ido-red uctase en-
zymes, and our suggestion that it might inhibit ON A synthcsis 
has been confirmed by Leibl et al and more recentl y by ourselves 
(Reith et aI, IRCS Med Sci 13:783-784, 1985). We are g ratified 
to receive further confirmation on this point by " labo ratory stLJd-
ies in prog rcss" in Boston . This question of a selective effect on 
abnormal melanocytes is , of course, important to understand . A 
recent stud y of ours (Picardo et aI , Biochem Pharmacol 
34:1653-1658, 1985) on no rmall ymph ocytcs and Iymphoma- and 
leukaemia-deri ved cell lines in culture, suggests it may be related 
to differences in permeability of the cell membrane. 
M any of the other points raised by Pathak et al have already 
been dea lt with in publications of ours listed in their bibliography, 
to which we refer your readers. Papers by Robins et al (Br J 
DermatoI113:687-697, 1985), Leibl et aJ 0 In vest DermatoI85:417-
422), Hu et al (B r J Dermatol 114:17-26, 1986) , and Geier et al 
(Hautarzt 37:146) are highly relevant to and supportive of the 
points made above. 
Elvira J. Robins , Ph. D. 
Aodan S. Brea thnach, M. D. 
Yash P. Bashin , B.Se. 
Leslie E thridge, F.I.S .T. 
Marce ll a Nazza ro-Porro, M .D. 
Siro Passi , Ph.D. 
Mauro Pi ca rdo, M . D. 
St. Mary's Hospita l Medica l School 
London, U.K. 
